Oxybutynin chloride syrup (oxybutynin chloride oral solution) is indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria).
Each 5 mL of oxybutynin chloride syrup (oxybutynin chloride oral solution) contains 5 mg of oxybutynin chloride, USP.
Chemically, oxybutynin chloride is d,l (racemic) 4-diethylamino-2-butynyl phenylcyclohexylglycolate hydrochloride. The empirical formula of oxybutynin chloride is C22H31NO3•HCl. The structural formula appears below:
Oxybutynin chloride is a white crystalline solid with a molecular weight of 393.9. It is readily soluble in water and acids, but relatively insoluble in alkalis.
Oxybutynin Chloride Syrup (Oxybutynin Chloride Oral Solution) also contains: Apple-Watermelon flavor, citric acid, FD&C Green #3, glycerin, methylparaben, purified water, sodium citrate, sorbitol solution, and sucrose.
Oxybutynin Chloride Syrup (Oxybutynin Chloride Oral Solution) is for oral administration.
The usual dose is one teaspoonful (5 mg/5 mL) of oral solution two to three times a day. The maximum recommended dose is one teaspoonful (5 mg/5 mL) of oral solution four times a day. A lower starting dose of 2.5 mg two or three times a day is recommended for the frail elderly.
Pediatric patients over 5 years of age:
The usual dose is one teaspoonful (5 mg/5 mL) of oral solution two times a day. The maximum recommended dose is one teaspoonful (5 mg/5 mL) of oral solution three times a day.
Adults:
The usual dose is one teaspoonful (5 mg/5 mL) of oral solution two to three times a day. The maximum recommended dose is one teaspoonful (5 mg/5 mL) of oral solution four times a day. A lower starting dose of 2.5 mg two or three times a day is recommended for the frail elderly.
Pediatric patients over 5 years of age:
The usual dose is one teaspoonful (5 mg/5 mL) of oral solution two times a day. The maximum recommended dose is one teaspoonful (5 mg/5 mL) of oral solution three times a day.
E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
Fluticasone Propionate Lotion | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
Fluticasone Propionate Lotion may be used in adult and pediatric patients 1 year of age or older. The safety and efficacy of Fluticasone Propionate Lotion in pediatric patients below 1 year of age have not been established (see PRECAUTIONS: Pediatric Use).
Atopic Dermatitis: Apply a thin film of Fluticasone Propionate Lotion to the affected skin areas once daily. Rub in gently.
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. The safety and efficacy of drug use for longer than 4 weeks have not been established.
Fluticasone Propionate Lotion should not be used with occlusive dressings or applied in the diaper area unless directed by a physician.
Fluticasone Propionate Lotion | Perrigo New York Inc
Fluticasone propionate lotion, 0.05% may be used in adult and pediatric patients 1 year of age or older. The safety and efficacy of fluticasone propionate lotion, 0.05% in pediatric patients below 1 year of age have not been established (see PRECAUTIONS: Pediatric Use).
Atopic Dermatitis – Apply a thin film of fluticasone propionate lotion, 0.05% to the affected skin areas once daily. Rub in gently. As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. The safety and efficacy of drug use for longer than 4 weeks have not been established. Fluticasone propionate lotion, 0.05% should not be used with occlusive dressings or applied in the diaper area unless directed by a physician.